Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WSC 2026 | Neutrophil extracellular traps in carotid artery stenosis: a new treatment target?

Gerrit M. Grosse, MD, PhD, University Hospital Basel, Basel, Switzerland, discusses the role of neutrophil extracellular traps (NETs) in carotid artery stenosis, highlighting their pro-thrombotic and pro-inflammatory properties. Dr Grosse notes that NETs may serve as a link between immunology and thrombogenicity, and that ongoing studies are investigating their role in atherosclerosis and cryptogenic stroke, potentially leading to a new treatment target. This interview took place at the 18th World Stroke Congress (WSC) in Seoul, Korea.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yeah, well, neutrophil extracellular traps are an emerging target indeed because these are like spilled out from the neutrophil granulocyte when they are activated and they are a very nice link between immunology and thrombogenicity. And what we know so far is that these nets are very pro-thrombotic and pro-inflammatory active and they can be degraded again with compounds and what we are now trying to investigate is the role of NETosis in atherosclerosis but also in cryptogenic stroke patients because that could be a missing link between inflammatory diseases and stroke...

Yeah, well, neutrophil extracellular traps are an emerging target indeed because these are like spilled out from the neutrophil granulocyte when they are activated and they are a very nice link between immunology and thrombogenicity. And what we know so far is that these nets are very pro-thrombotic and pro-inflammatory active and they can be degraded again with compounds and what we are now trying to investigate is the role of NETosis in atherosclerosis but also in cryptogenic stroke patients because that could be a missing link between inflammatory diseases and stroke. So that could really have an impact on a large scale of stroke patients and studies are ongoing and hopefully we can address this shortly.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.